dipyridamole has been researched along with alprostadil in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (55.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Lee, CN; Vincent, DL; Weems, CW; Weems, YS | 2 |
| Frauchiger, B | 1 |
| Bochner, F; Duncan, B; Duncan, E; Gregov, D; Jenkins, A; Lloyd, J; Rodgers, S; Siebert, D | 1 |
| Furukawa, T; Inoue, T; Katsuragi, T | 1 |
| Forn, J; García-Rafanell, J; Gomez, L; Ramis, J | 1 |
| Nagamatsu, T; Suzuki, Y | 1 |
| Pilger, E | 1 |
| Denko, CW | 1 |
| Kakkar, VV; Zahavi, J; Zahavi, M | 1 |
| Coquil, JF; Franks, DJ; Hamet, P; Tremblay, J | 1 |
| Biland, L; Bollinger, A; Brunner, U; Kappert, A; Krähenbühl, B; Mahler, F; Monti, M; Nachbur, B; Schneider, E; Widmer, LK | 1 |
| Hatmi, M; Touqui, L; Vargaftig, BB | 1 |
| Aubert, D; Ferrand, C; Loubrie, JC; Tuong, A; Tuong, CC | 1 |
| Berzetei-Gurske, I; Bivalacqua, TJ; Champion, HC; Doherty, PC; Greenwood-Van Meerveld, B; Hellstrom, WJ; Kadowitz, PJ | 1 |
| Butenas, S; Cawthern, KM; DiLorenzo, ME; Lock, JB; Mann, KG; van't Veer, C | 1 |
| Aktas, B; Geiger, J; Hoenig-Liedl, P; Utz, A; Walter, U | 1 |
2 trial(s) available for dipyridamole and alprostadil
| Article | Year |
|---|---|
Dipyridamole: pharmacokinetics and effects on aspects of platelet function in man.
Topics: Adolescent; Adult; Alprostadil; Blood Platelets; Cyclic AMP; Dipyridamole; Female; Humans; Male; Platelet Aggregation; Thromboxane A2 | 1987 |
Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
Topics: Adult; Alprostadil; Blood Platelets; Cell Adhesion Molecules; Cyclic GMP; Delayed-Action Preparations; Dipyridamole; Female; Humans; In Vitro Techniques; Male; Microfilament Proteins; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase Inhibitors; Phosphoproteins; Phosphorylation; Platelet Aggregation Inhibitors; Reference Values; Serotonin; Signal Transduction; Vasodilator Agents | 2003 |
18 other study(ies) available for dipyridamole and alprostadil
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Adenosine facilitates the response to HCG, PGE1 or PGE2 and inhibits the response to PGF2 alpha by HCG-stimulated ovine luteal cells in vitro.
Topics: Adenosine; Alprostadil; Animals; Cell Survival; Chorionic Gonadotropin; Dinoprost; Dinoprostone; Dipyridamole; Drug Interactions; Female; Luteal Cells; Progesterone; Sheep | 1992 |
The purine adenosine amplifies the response to gonadotropins and inhibits prostaglandin F2 alpha (PGF2 alpha) suppression of gonadotropin stimulation of bovine luteal cells in vitro.
Topics: Adenosine; Alprostadil; Animals; Cattle; Chorionic Gonadotropin; Corpus Luteum; Dinoprost; Dinoprostone; Dipyridamole; Drug Synergism; Estrus; Female; Gonadotropins; Humans; Progesterone | 1991 |
[Conservative therapy of peripheral arterial occlusive disease].
Topics: Alprostadil; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Exercise; Humans; Life Style; Platelet Aggregation Inhibitors | 1990 |
Antagonism by clonidine of the adenosine-induced inhibition of the twitch contraction of the guinea-pig Oddi sphincter.
Topics: Adenosine; Alprostadil; Ampulla of Vater; Animals; Clonidine; Dipyridamole; Electric Stimulation; Guinea Pigs; Hexamethonium; Hexamethonium Compounds; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Phenylisopropyladenosine; Prostaglandins E; Reserpine; Sphincter of Oddi; Theophylline; Yohimbine | 1985 |
Effect of triflusal and other salicylic acid derivatives on cyclic AMP levels in rat platelets.
Topics: Alprostadil; Animals; Aspirin; Blood Platelets; Cyclic AMP; Dipyridamole; Drug Interactions; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Salicylates; Salicylic Acid | 1986 |
Effects of prostaglandin E1 and dipyridamole on disposal of colloidal carbon via glomerular mesangial channels.
Topics: Alprostadil; Animals; Carbon; Colloids; Dipyridamole; Kidney Glomerulus; Male; Rats; Rats, Inbred Strains | 1987 |
[Computer-assisted in vivo study of capillary permeability].
Topics: Adolescent; Adult; Aged; Alprostadil; Arterial Occlusive Diseases; Aspirin; Capillary Permeability; Collagen Diseases; Computers; Cyanosis; Dipyridamole; Drug Therapy, Combination; Factor XIII; Female; Heparin; Humans; Male; Microcomputers; Middle Aged; Nails; Phenprocoumon; Raynaud Disease; Rheology; Streptokinase | 1985 |
Cryoglobulin-induced inflammation.
Topics: Alprostadil; Animals; Choline; Colchicine; Cryoglobulins; Crystallization; Dipyridamole; Drug Combinations; Fatty Acids, Essential; Inflammation; Male; Rats; Rats, Inbred Strains; Salicylates | 1985 |
Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
Topics: Adenylyl Cyclases; Adult; Alprostadil; Blood Platelets; Cyclic AMP; Dipyridamole; Female; Humans; Hydantoins; Male; Middle Aged; Papaverine; Phosphodiesterase Inhibitors; Platelet Aggregation; Prostaglandins E; Pyridoxal Phosphate; Theophylline | 1984 |
Rapid activation of cAMP phosphodiesterase in rat platelets.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Alprostadil; Animals; Blood Platelets; Calcimycin; Calcium; Dipyridamole; Enzyme Activation; Epoprostenol; Indomethacin; Papaverine; Prostaglandins E; Protein Kinases; Rats | 1983 |
[Therapy of peripheral arterial occlusive diseases. Round table conference].
Topics: Alprostadil; Angioplasty, Balloon; Anti-Bacterial Agents; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Dipyridamole; Endarterectomy; Exercise Therapy; Fibrinolysis; Humans; Hyperlipidemias; Hypertension; Infusions, Intra-Arterial; Intermittent Claudication; Prostaglandins E; Serotonin Antagonists; Sympathectomy; Thromboxane A2 | 1983 |
Interactions between dipyridamole and prostaglandin E1 with ADP-induced aggregation of rat platelet in whole blood.
Topics: Adenosine Diphosphate; Alprostadil; Animals; Dipyridamole; Drug Interactions; Male; Platelet Aggregation; Prostaglandins E; Rats; Rats, Inbred Strains | 1984 |
Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
Topics: Adenosine Diphosphate; Alprostadil; Animals; Aspirin; Dipyridamole; Male; Phosphorylation; Platelet Aggregation; Prostaglandins E; Rats; Rats, Inbred Strains; Sulfinpyrazone; Thiophenes; Ticlopidine | 1982 |
Direct effects of selective type 5 phosphodiesterase inhibitors alone or with other vasodilators on the erectile response in cats.
Topics: Alprostadil; Animals; Cats; Dipyridamole; Dose-Response Relationship, Drug; Male; Nitroprusside; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Purinones; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2001 |
Antiplatelet agents in tissue factor-induced blood coagulation.
Topics: Abciximab; Adult; Alprostadil; Animals; Antibodies, Monoclonal; Antithrombin III; Aspirin; Blood Coagulation; Dipyridamole; Eptifibatide; Fibrinopeptide A; Humans; Immunoglobulin Fab Fragments; Mice; Osteonectin; Partial Thromboplastin Time; Peptide Hydrolases; Peptides; Plant Proteins; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proteins; Prothrombin Time; Receptors, Thrombin; Thromboplastin | 2001 |